Angelica Petrillo, President of Gastro Oncology Young ETS, shared a post on LinkedIn:
“ESMO GI 2026 is approaching- save the date for ASPIRE!
If you’re attending ESMOGI26, don’t miss the Rapid Oral Session on Innovation, where I’ll have the pleasure of presenting the ASPIRE study results on behalf of the EORTC GI Group.
Title: Interchangeability of PD-L1 assays and scoring methods in gastroesophageal adenocarcinoma
Saturday, July 4
09:35 CET
Room 13a
Looking forward to sharing our findings and discussing their implications with colleagues.”
European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn by Angelica Petrillo, adding:
“Don’t miss this Rapid Oral Session on Saturday at ESMOGI, where Angelica Petrillo will present the ASPIRE study results.
The ASPIRE study is the first global study evaluating the interchangeability of PD-L1 scoring systems and assays in GC.”
